SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Therapeutics (CTIC)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
946 45 0 CTIC
Emcee:  Regis McConnell Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
196Bad timing ? <i>09.03.2004 11:49 GPC Biotech stellt Entwicklung von BryosIcebrg-3/16/2004
195[Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and tuck-3/16/2004
194Arsenic Study May Point to Leukemia Treatments Mon Mar 15, WASHINGTON (Reutersnigel bates-3/16/2004
193Cell Therapeutics countersues over cancer-drug testing By Luke Timmerman SeattlIcebrg-3/12/2004
192Cell Therapeutics, Inc. to Initiate Pivotal Trial for Pixantrone in Relapsed AggIcebrg-3/4/2004
191Cephalon to work on R&D with Italian company John George May 7, 2002 [Some Icebrg-2/28/2004
190>>Clinical Cancer Research Vol. 10, 1508-1520, February 2004 Experimentaltuck-2/24/2004
189Cell Therapeutics sued by Munich-based Micromet WILMINGTON, Del. — Cell TherapeIcebrg-2/20/2004
188Amusing action today - well, let's think this over, doesn't look good, dtom pope-2/11/2004
187>>When you say orphan drug status gives them a couple fo extra years in EuIcebrg-2/11/2004
186Thanks. No wonder they needed an existing force. When you say orphan drug stattuck-2/11/2004
185>> Big news day for CTIC, which is following its TRISENOX patent allowanceIcebrg-2/11/2004
184>>SEATTLE, Feb. 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)tuck-2/11/2004
183Big news day for CTIC, which is following its TRISENOX patent allowance with an tuck-2/11/2004
182<i>Would it not be possible to blind?</i> Realistically no - it'Biomaven-2/10/2004
181FWIW, the protocol for Pixantrone PIII. Why open label? As it's randomizedtuck-2/9/2004
180TRISENOX(R) U.S. Patent Allowance Will Extend Exclusivity from 2007 to Late 2018Icebrg-1/27/2004
179Trials of Arsenic Trioxide in Multiple Myeloma Posted 01/06/2004 Mohamad A. HussIcebrg-1/14/2004
178The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxiIcebrg-1/14/2004
177Press Release Source: Cell Therapeutics, Inc. Cell Therapeutics Honored with KThai Chung-1/8/2004
176Arsenic Trioxide Enhances Radiation Response of 9L Glioma in the Rat Brain Jae Icebrg-1/7/2004
175New Directions in the Management of Multiple Myeloma: An Interview With William Icebrg-12/17/2003
174Treatment Protocol With Arsenic and Retinoic Acid Highly Effective for APL CharIcebrg-12/17/2003
173Dow Jones Business News Cell Therapeutics Reports Positive Data From Trisenox StThai Chung-12/9/2003
172TRISENOX(R) Regimen Produces High Response Rates in Patients With Relapsed Or ReIcebrg-12/9/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News